Portal de Periódicos da CAPES

Metabolic Dysfunction in Aortic Stenosis: A Key Piece of the Pathophysiological Puzzle

2023; Lippincott Williams & Wilkins; Volume: 16; Issue: 10 Linguagem: Inglês

10.1161/circimaging.123.015977

1942-0080

David E. Sosnovik, Sammy Elmariah,

Cardiovascular Function and Risk Factors

HomeCirculation: Cardiovascular ImagingVol. 16, No. 10Metabolic Dysfunction in Aortic Stenosis: A Key Piece of the Pathophysiological Puzzle No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextMetabolic Dysfunction in Aortic Stenosis: A Key Piece of the Pathophysiological Puzzle David E. Sosnovik and Sammy Elmariah David E. SosnovikDavid E. Sosnovik Correspondence to: David Sosnovik, MD, Martinos Center for Biomedical Imaging, Massachusetts General Hospital, 149 13th St, Charlestown MA 02129. Email E-mail Address: [email protected] https://orcid.org/0000-0002-6486-7434 Martinos Center for Biomedical Imaging (D.E.S.), Massachusetts General Hospital, Harvard Medical School, Boston. Cardiovascular Research Center and Cardiology Division (D.E.S.), Massachusetts General Hospital, Harvard Medical School, Boston. and Sammy ElmariahSammy Elmariah https://orcid.org/0000-0002-8013-8733 Division of Cardiology, Department of Medicine, University of California San Francisco (S.E.). Originally published17 Oct 2023https://doi.org/10.1161/CIRCIMAGING.123.015977Circulation: Cardiovascular Imaging. 2023;16This article is a commentary on the followingRole of Cardiac Energetics in Aortic Stenosis Disease Progression: Identifying the High-risk Metabolic PhenotypeFootnotesFor Sources of Funding and Disclosures, see page 790.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: David Sosnovik, MD, Martinos Center for Biomedical Imaging, Massachusetts General Hospital, 149 13th St, Charlestown MA 02129. Email dsosnovik@mgh.harvard.eduREFERENCES1. Dahl JS, Magne J, Pellikka PA, Donal E, Marwick TH. Assessment of subclinical left ventricular dysfunction in aortic stenosis.JACC Cardiovasc Imaging. 2019; 12:163–171. doi: 10.1016/j.jcmg.2018.08.040CrossrefMedlineGoogle Scholar2. Peterzan MA, Clarke WT, Lygate CA, Lake HA, Lau JYC, Miller JJ, Johnson E, Rayner JJ, Hundertmark MJ, Sayeed R, et al. Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction.Circulation. 2020; 141:1971–1985. doi: 10.1161/CIRCULATIONAHA.119.043450LinkGoogle Scholar3. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, Banya W, Gulati A, Roussin I, Raza S, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis.J Am Coll Cardiol. 2011; 58:1271–1279. doi: 10.1016/j.jacc.2011.03.064CrossrefMedlineGoogle Scholar4. Elmariah S, Farrell LA, Furman D, Lindman BR, Shi X, Morningstar JE, Rhee EP, Gerszten RE. Association of acylcarnitines with left ventricular remodeling in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.JAMA Cardiol. 2018; 3:242–246. doi: 10.1001/jamacardio.2017.4873CrossrefMedlineGoogle Scholar5. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.N Engl J Med. 2019; 380:1706–1715. doi: 10.1056/NEJMoa1816885CrossrefMedlineGoogle Scholar6. Monga S, Valkovič L, Myerson SG, Neubauer S, Mahmod M, Rider OJ. Role of cardiac energetics in aortic stenosis disease progression: identifying the high-risk metabolic phenotype.Circ Cardiovasc Imaging. 2023; 16:e014863. doi: 10.1161/CIRCIMAGING.122.014863LinkGoogle Scholar7. Panagia M, Chen HH, Croteau D, Iris Chen YC, Ran C, Luptak I, Josephson L, Colucci WS, Sosnovik DE. Multiplexed optical imaging of energy substrates reveals that left ventricular hypertrophy is associated with brown adipose tissue activation.Circ Cardiovasc Imaging. 2018; 11:e007007. doi: 10.1161/CIRCIMAGING.117.007007LinkGoogle Scholar8. Perry AS, Zhao S, Murthy V, Gupta DK, Fearon WF, Kim JB, Kapadia S, Kumbhani DJ, Gillam L, Whisenant B, et al. Metabolic signatures of cardiac dysfunction, multimorbidity, and post-transcatheter aortic valve implantation death.J Am Heart Assoc. 2023; 12:e029542. doi: 10.1161/JAHA.123.029542LinkGoogle Scholar9. Stein EJ, Fearon WF, Elmariah S, Kim JB, Kapadia S, Kumbhani DJ, Gillam L, Whisenant B, Quader N, Zajarias A, et al. Left ventricular hypertrophy and biomarkers of cardiac damage and stress in aortic stenosis.J Am Heart Assoc. 2022; 11:e023466. doi: 10.1161/JAHA.121.023466LinkGoogle Scholar10. Lai L, Leone TC, Keller MP, Martin OJ, Broman AT, Nigro J, Kapoor K, Koves TR, Stevens R, Ilkayeva OR, et al. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.Circ Heart Fail. 2014; 7:1022–1031. doi: 10.1161/CIRCHEARTFAILURE.114.001469LinkGoogle Scholar11. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2021; 143:e72–e227. doi: 10.1161/CIR.0000000000000923LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Sengupta P and Chandrashekhar Y (2024) Advancing Myocardial Tissue Analysis Using Echocardiography, JACC: Cardiovascular Imaging, 10.1016/j.jcmg.2024.01.002, 17:2, (228-231), Online publication date: 1-Feb-2024. Related articlesRole of Cardiac Energetics in Aortic Stenosis Disease Progression: Identifying the High-risk Metabolic PhenotypeShveta Monga, et al. Circulation: Cardiovascular Imaging. 2023;16 October 2023Vol 16, Issue 10 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCIMAGING.123.015977PMID: 37847765 Originally publishedOctober 17, 2023 KeywordsEditorialsaortic valve stenosishypertrophymetabolismmyocardiumPDF download Advertisement SubjectsMagnetic Resonance Imaging (MRI)MetabolismMyocardial BiologyPathophysiologyTranslational Studies